Overview

Study Assessing the Effects of Chemotherapy in Advanced Esophagogastric Adenocarcinoma

Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to determine the effects of treatment with carboplatin, docetaxel and capecitabine in patients with incurable cancer of the esophagus or stomach.
Phase:
Phase 2
Details
Lead Sponsor:
Rigshospitalet, Denmark
Treatments:
Capecitabine
Carboplatin
Docetaxel
Epirubicin
Oxaliplatin